Gabriele Fischer

Prof. Dr. Gabriele Fischer, qualified from the Medical University of Vienna in 1984, where she went on to specialise in psychiatry and neurology, with a fellowship at Washington University Medical School, St. Louis; US (1986-1989). In 1994, she became the Medical Director of the Addiction Clinic at the Medical University Vienna, Austria. gabriele.fischer@meduniwien.ac.at.
Prof Fischer has been involved in many epidemiological and psychopharmacological studies in substance dependence, as well as her pioneering work in the research of substance dependence and pregnancy, which resulted in many scientific publications in addition to national & international funding eg: NIH/NIDA funding on the topic of a prospective multicentre trial on methadone versus buprenorphine in pregnancy (MOTHER). She is a consultant for several international and national groups including the United Nations Office on Drugs and Crime (UNODC) and the World Health Organization (WHO), and is also a board member of the Quality Control Commission in Medicine in Austria. To date she has given over 400 scientific presentations and has over 150 scientific publications. Prof Fischer is also involved in editorial and review work for many psychiatric journals, is a board member of several addiction societies.